News & Blog

Tag Archives: biotechnology

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

Can this treatment help me live a longer and better life?

Why was I asked to sit on a panel with two top officials from the U.S. Food and Drug Administration (FDA), two leading neuro-oncologists, an associate professor of neuropsychiatry, and an executive from the biopharmaceutical company, Genentech? Because, as a five-year brain tumor survivor and volunteer advocate with the National Brain Tumor Society, I want […]

Share